Antacids Containing Aluminum Interactions

May decrease absorption of CHENODIOL in the intestine and result in decreased efficacy. Concomitant use should be avoided.

Source: NLP:chenodiol

Reduces rate and extent of cefdinir absorption by approximately 40% and prolongs time to peak concentration by 1 hour. No significant effect if administered 2 hours before or after cefdinir.

Source: NLP:cefdinir

Absorption of tetracyclines is impaired by antacids containing aluminum.

Source: NLP:doxycycline

Aluminum-containing antacids impair absorption of tetracyclines.

Source: NLP:doxycycline hyclate

May interfere with gastrointestinal absorption of levofloxacin, resulting in systemic levels considerably lower than desired. Should be taken at least two hours before or after levofloxacin.

Source: NLP:levofloxacin

Antacids containing aluminum impair absorption of tetracyclines.

Source: NLP:minocycline hydrochloride

Aluminum-containing antacids may bind phosphate and prevent its absorption.

Source: NLP:potassium phosphate, monobasic and sodium phosphate, monobasic, anhydrous

Coadministration may impair SEYSARA absorption and decrease efficacy. Separate dosing required.

Source: NLP:sarecycline hydrochloride

May bind phosphate and prevent its absorption.

Source: NLP:dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate

High levels of aluminum from concomitant medications may alter biodistribution of technetium Tc 99m pyrophosphate, reducing skeletal uptake and increasing extraosseous uptake, potentially degrading imaging quality.

Source: NLP:technetium tc 99m pyrophosphate

May interfere with ursodiol action by adsorbing bile acids and reducing ursodiol absorption.

Source: NLP:ursodiol

May interfere with ursodiol action by adsorbing bile acids, similar to bile acid sequestering agents.

Source: NLP:usodiol